Post-market surveillance

Reliable Active Surveillance: RWE for MedTech

By Amelia Hufford, PhD, Phillip Stoltzfus

…challenge. Introduction to aiSurveillance aiSurveillance is a new approach combining data science and clinical science, developed specifically for the MedTech industry. aiSurveillance software integrates real-world data (RWD) sources, such as…

…challenge. Introduction to aiSurveillance aiSurveillance is a new approach combining data science and clinical science, developed specifically for the MedTech industry. aiSurveillance software integrates real-world data (RWD) sources, such as…

Continue reading

Nicole Coustier

Reimbursement DĆ©jĆ  Vu: Lessons for AI/ML Medtech Founders from the Molecular Diagnostics Industry

By Nicole Coustier

…pioneering molecular diagnostic test for breast cancer, and Viz.ai, an AI-powered platform originally approved for stroke detection, serve as illustrative case studies. By examining the specific hurdles encountered by these…

…pioneering molecular diagnostic test for breast cancer, and Viz.ai, an AI-powered platform originally approved for stroke detection, serve as illustrative case studies. By examining the specific hurdles encountered by these…

Continue reading

LDT-laboratory Developed Test

FDA under fire: Pared-down LDT Final Rule leaves unanswered questions

By Hogan Lovells Engage

test and make modifications. The Final Rule makes clear that the agency plans to exercise enforcement discretion over such modified third party-developed and legally marketed tests if: the original test

test and make modifications. The Final Rule makes clear that the agency plans to exercise enforcement discretion over such modified third party-developed and legally marketed tests if: the original test

Continue reading

Combination Devices: new guidance for industry and notified bodies

…considerations on the implementation of the medical devices and in vitro diagnostic regulations for combinations of medicinal products and medical devices. Products that combine a medicinal product (or substance) and…

…considerations on the implementation of the medical devices and in vitro diagnostic regulations for combinations of medicinal products and medical devices. Products that combine a medicinal product (or substance) and…

Continue reading

CUE Health lays off entire staff

By MedTech Intelligence Staff

According to SFGate, the San Diego-based medical tech company announced Monday that it is laying off its entire staff. Similar industry reports indicate a complete shuttering of operations. Today’s announcement…

According to SFGate, the San Diego-based medical tech company announced Monday that it is laying off its entire staff. Similar industry reports indicate a complete shuttering of operations. Today’s announcement…

Continue reading

Healthcare Technology

The Role of EPSS in Prioritizing IoMT Security Threats

By Shankar Somasundaram

…FIRST, https://www.first.org/epss/model [iii] “Exploit Prediction Scoring System,” FIRST, https://www.first.org/epss/ [iv] “Common Vulnerability Scoring System SIG,” FIRST, https://www.first.org/cvss/ [v] “Exploit Prediction Scoring System,” FIRST, https://www.first.org/epss/ [vi] “NIST Cybersecurity Framework, NIST, https://www.nist.gov/cyberframework…

…FIRST, https://www.first.org/epss/model [iii] “Exploit Prediction Scoring System,” FIRST, https://www.first.org/epss/ [iv] “Common Vulnerability Scoring System SIG,” FIRST, https://www.first.org/cvss/ [v] “Exploit Prediction Scoring System,” FIRST, https://www.first.org/epss/ [vi] “NIST Cybersecurity Framework, NIST, https://www.nist.gov/cyberframework…

Continue reading

HeartFlow Logo

HeartFlow AI Plaque Analysis Shows 95% Accuracy vs. Invasive Imaging

By MedTech Intelligence Staff

The multicenter international study, which enrolled 258 patients across 15 sites in the U.S. and Japan, compared HeartFlow’s automated deep-learning-based method for segmenting coronary atherosclerosis in coronary computed tomography angiography…

The multicenter international study, which enrolled 258 patients across 15 sites in the U.S. and Japan, compared HeartFlow’s automated deep-learning-based method for segmenting coronary atherosclerosis in coronary computed tomography angiography…

Continue reading